Jianwei Zhou

Years Active: 2020-2023
Publications (10 Years): 6

School of Public Health, Nanjing Medical University

Nanjing Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

School of Public Health, Nanjing Medical University Jul 08 2001

China

Professor :: Department of Molecular Cell Biology & Toxicology

Education History

Nanjing Medical University Jul 08 2003

China

PHD

Publications

Lu Zou, Zhen Che, Kun Ding, Chao Zhang, Xia Liu, Luman Wang, Aiping Li, Jianwei Zhou
JAC4 Alleviates Rotenone-Induced Parkinson's Disease through the Inactivation of the NLRP3 Signal Pathway. Antioxidants (Basel, Switzerland) 12 (5) (2023)
Kun Ding, Xuqian Jiang, Zhangding Wang, Lu Zou, Jiahua Cui, Xiong Li, Chuanjun Shu, Aiping Li, Jianwei Zhou
JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis. International journal of molecular sciences 24 (10) (2023)
Zurong Zhai, Yanlin Ren, Chuanjun Shu, Dongyin Chen, Xia Liu, Yan Liang, Aiping Li, Jianwei Zhou
JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC. Cell death discovery 8 (1) (2022)
Kun Ding, Xia Liu, Luman Wang, Lu Zou, Xuqian Jiang, Aiping Li, Jianwei Zhou
Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery. Cancers 14 (19) (2022)
Yan Zhou, Jingwen Liu, Xiong Li, Luman Wang, Lirong Hu, Aiping Li, Jianwei Zhou
JAC4 Protects from X-ray Radiation-Induced Intestinal Injury by JWA-Mediated Anti-Oxidation/Inflammation Signaling. Antioxidants (Basel, Switzerland) 11 (6) (2022)
Na Fang, Yijun Shi, Yu Fan, Tao Long, Yongqian Shu, Jianwei Zhou
Circ_0072088 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Cancer by Absorbing miR-377. Journal of oncology 2020 (2020)

Jianwei Zhou.css-eqlu8i{font-size:small;padding-left:4px;}